Transpact Enterprises Ltd
TRANSPACTTranspact Enterprises Ltd
TRANSPACTPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 17.97 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Transpact Enterprises is engaged in the design, development, manufacturing, and distribution of therapeutic devices and rehabilitations services.
Peers
Compare with peersPoly Medicure Ltd
Tarsons Products Ltd
Borosil Scientific Ltd
Balaxi Pharmaceuticals Ltd
Universus Photo Imagings Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.00 | 0.00 | 0.00 | 0.13 | 0.02 | 0.06 | 0.18 | 0.38 | 0.00 | — | ||||||||||
Raw Materials | 0.07 | 0.00 | 0.21 | 0.09 | 0.09 | 0.00 | 0.11 | 0.19 | 0.00 | — | ||||||||||
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Employee Cost | 0.01 | 0.04 | 0.01 | 0.02 | 0.03 | 0.04 | 0.11 | 0.02 | ||||||||||||
Selling & Administrative Expenses | 0.00 | 0.00 | 0.06 | 0.31 | 0.05 | 0.04 | 0.00 | 0.00 | ||||||||||||
Operating & Other expenses | 0.04 | -0.16 | 0.24 | -0.08 | -0.01 | 0.17 | 0.11 | 0.04 | ||||||||||||
EBITDA | -0.07 | -0.05 | -0.09 | -0.27 | -0.32 | -0.01 | -0.18 | -0.03 | -0.06 | — | ||||||||||
Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | — | ||||||||||
PBIT | -0.07 | -0.05 | -0.09 | -0.29 | -0.36 | -0.05 | -0.22 | -0.07 | -0.10 | — | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
PBT | -0.07 | -0.05 | -0.09 | -0.29 | -0.43 | -0.05 | -0.22 | -0.07 | -0.10 | — | ||||||||||
Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Net Income | -0.07 | -0.05 | -0.09 | -0.30 | -0.44 | -0.06 | -0.22 | -0.07 | -0.10 | — | ||||||||||
EPS | -4.05 | -1.79 | -3.18 | -10.61 | -13.14 | -1.55 | -5.69 | -1.81 | -2.59 | — | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Transpact Enterprises Ltd | -80.87 | 17.97 | — |
Poly Medicure Ltd | 109.11 | 19.17 | 0.10% |
Tarsons Products Ltd | 54.52 | 3.79 | 0.46% |
Borosil Scientific Ltd | 70.33 | 4.40 | — |
Price Comparison
Compare TRANSPACT with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
TRANSPACT has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Transpact Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
Transpact Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
Transpact Enterprises will hold a meeting of the Board of Directors of the Company on 30 August 2024.Powered by Capital Market - Live
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 2.07%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant